Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: Results of the MAIN-AF study

Journal of Cardiology

Volumn 62, Issue 1, 2013, Pages 50-57

  Yamashita, Takeshi ^a   Inoue, Hiroshi ^b  

^a THE CARDIOVASCULAR INSTITUTE   (Japan)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Atrial fibrillation; Bisoprolol; Heart rate

Indexed keywords

BISOPROLOL;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; FEMALE; HEART ATRIUM FIBRILLATION; HEART RATE; HOLTER MONITORING; HUMAN; JAPAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL; RESTING HEART RATE; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ATRIAL FIBRILLATION; BISOPROLOL; HEART RATE;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADULT; AGED; ATRIAL FIBRILLATION; BISOPROLOL; BLOOD PRESSURE; CHRONIC DISEASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84880045401     PISSN: 09145087     EISSN: 18764738     Source Type: Journal    
DOI: 10.1016/j.jjcc.2013.02.010     Document Type: Article

References (15)

1. Wyse D.G., Waldo A.L., DiMarco J.P., Domanski M.J., Rosenberg Y., Schron E.B., Kellen J.C., Greene H.L., Mickel M.C., Dalquist J.E., Corley S.D. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002, 347:1825-1833. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators.
2. Ogawa S., Yamashita T., Yamazaki T., Aizawa Y., Atarashi H., Inoue H., Ohe T., Ohtsu H., Okumura K., Katoh T., Kamakura S., Kumagai K., Kurachi Y., Kodama I., Koretsune Y., et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J 2009, 73:242-248.
3. Fuster V., Rydén L.E., Cannom D.S., Crijns H.J., Curtis A.B., Ellenboden K.A., Halperin J.L., Le Heuzey J.Y., Kay G.N., Lowe J.E., Olsson S.B., Prystowsky E.N., Tamargo J.L., Wann S., Smith S.C., et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2006, 48:e149-e246.
4. Guidelines for pharmacotherapy of atrial fibrillation (JCS 2008). Circ J 2010, 74:2479-2500. JCS Joint Working Group.
5. Kodama I, Aizawa Y, Atarashi H, Inoue H, Ogawa S, Okumura K, Katoh T, Kamiya K, Saikawa T, Sugi K, Sumitomo N, Nakaya H, Mitamura H, Yamashita T, Ohara T, et al. Guidelines for drug treatment of arrhythmias (JCS 2009). Available at: [accessed 16.10.12; in Japanese]. http://www.j-circ.or.jp/guideline/pdf/JCS2009_kodama_h.pdf.
6. Atarashi H. Results of questionnaire survey on atrial fibrillation treatment guidelines. Prog Med 2008, 28:1577-1592. [in Japanese].
7. Ishiguro H., Ikeda T., Tsukada T., Abe A., Miwa Y., Miyakoshi M., Hoshida K., Yanagisawa R., Mera H., Yusu S., Yoshino H. Changes in heart rate and blood pressure with different doses of the selective β1-blocker bisoprolol in patients with atrial fibrillation. J Clin Ther Med 2010, 26:911-919. [in Japanese].
8. Tsuneda T., Yamashita T., Fukunami M., Kumagai K., Niwano S., Okumura K., Inoue H. Rate control and quality of life in patients with permanent atrial fibrillation - the quality of life and atrial fibrillation (QOLAF) study. Circ J 2006, 70:965-970.
9. Ishiguro H., Ikeda T., Abe A., Tsukada T., Mera H., Nakamura K., Yusu S., Yoshino H. Antiarrhythmic effect of bisoprolol, a highly selective b1-blocker, in patients with paroxysmal atrial fibrillation. Int Heart J 2008, 49:281-293.
10. Shimizu A. My views on treating atrial fibrillation: from the standpoint of rate control. J Cardiol Jpn Ed 2010, 5:26-31. [in Japanese].
11. Van Gelder I.C., Hagens V.E., Bosker H.A., Kingma J.H., Kamp O., Kingma T., Said S.A., Darmanata J.I., Timmermans A.J., Tijssen J.G., Crijns H.J. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002, 347:1834-1840. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group.
12. Carlsson J., Miketic S., Windeler J., Cuneo A., Haun S., Micus S., Walter S., Tebbe U. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol 2003, 41:1690-1696. STAF Investigators.
13. Murakami M., Niwano S., Koitabashi T., Inomata T., Satoh A., Kishihara J., Ishikawa S., Aoyama Y., Niwano H., Izumi T. Evaluation of the impact of atrial fibrillation on rehospitalization events in heart failure patients in recent years. J Cardiol 2012, 60:36-41.
14. Van Gelder I.C., Groenveld H.F., Crijns H.J., Tuininga Y.S., Tijssen J.G., Alings A.M., Hillege H.L., Bergsma-Kadijk J.A., Cornel J.H., Kamp O., Tukkie R., Bosker H.A., Van Veldhuisen D.J., Van den Berg M.P. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010, 362:1363-1373. RACE II Investigators.
15. Hirano K., Yamashita T., Suzuki S., Hayama E., Matsuoka J., Otsuka T., Sagara K., Fu L.T., Sawada H., Aizawa T., Nakazato Y., Daida H. Relationship between 24-h Holter recordings and clinical outcomes in patients with permanent atrial fibrillation. J Cardiol 2012, 60:42-46.